93. Kynurenine Pathway Dysregulation in Bipolar Disorder: Implications for Clinical Heterogeneity

Simple item page
dc.contributor.authorMete Ercis
dc.contributor.authorLindsay Melhuish Beaupre
dc.contributor.authorPatrik Fridh
dc.contributor.authorJacob Ahlberg Weidenfors
dc.contributor.authorReswanul Khan
dc.contributor.authorBrandon J. Coombes
dc.contributor.authorAlfredo B. Cuéllar‐Barboza
dc.contributor.authorMiguel L. Prieto
dc.contributor.authorSusan L. McElroy
dc.contributor.authorAyşegül Özerdem
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:35:24Z
dc.date.available2026-03-22T19:35:24Z
dc.date.issued2025
dc.identifier.doi10.1016/j.biopsych.2025.02.330
dc.identifier.urihttps://doi.org/10.1016/j.biopsych.2025.02.330
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/76941
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofBiological Psychiatry
dc.sourceWinnMed
dc.subjectKynurenine pathway
dc.subjectBipolar disorder
dc.subjectImmune dysregulation
dc.subjectNeuroscience
dc.subjectMedicine
dc.subjectPsychology
dc.subjectKynurenine
dc.title93. Kynurenine Pathway Dysregulation in Bipolar Disorder: Implications for Clinical Heterogeneity
dc.typearticle

Files

Collections

Artículo Científico Publicado